2nd Quarter - Report
AMERICAN CAPITOL GROUP for C-PATH INSTITUTE
Client
Income
$15,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Funding for Critical Path Programs at FDA
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVE LARSON | — |
Health Issues HCR
FDA Issues. Act for ALS Legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVE LARSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.